Royal Commission examines the use of psychotropic medication to address behaviours of concern exhibited by people with disability
In September 2020, the Royal Commission into Violence, Abuse, Neglect and Exploitation of People with Disability held its sixth public hearing.
The hearing examined the use of psychotropic medication to address behaviours of concern exhibited by people with disability.
Among the many witnesses present during the hearing was Professor Keith McVilly, Professorial Fellow in Disability and Social Inclusion in the research partnership between Scope and the University of Melbourne.
In this instance, Professor McVilly spoke to the Commission as a clinical psychologist and an academic.
During his statement, Professor McVilly discussed the extent of reliance on Psychotropic medications for people with disability and how drugs such as anti-psychotics, anti-depressants, and mood stabilisers have been ‘misuse[d] and overuse[d]’.
He also shared an upcoming program that will be implemented in partnership with the University of Melbourne and our own Positive Behaviour Support Service. This program involves comprehensive behaviour support training for disability support workers.
Scope supports the Royal Commission because we regard it as another development that helps to advance the rights of people with disability. It is consistent with our own mission to enable each person we support to live as an empowered and equal citizen.
You can view Professor McVilly’s full statement on the Royal Commission’s website.
Visit the Royal Commission’s website to access the online hearings.